Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Change in Inventory (2023 - 2026)

BioScience Health Innovations has reported Change in Inventory over the past 4 years, most recently at $537992.0 for Q1 2026.

  • Quarterly Change in Inventory rose 241.85% to $537992.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $658644.0 through Mar 2026, up 275.8% year-over-year, with the annual reading at $278029.0 for FY2025, 1248.54% up from the prior year.
  • Change in Inventory was $537992.0 for Q1 2026 at BioScience Health Innovations, up from -$421152.0 in the prior quarter.
  • Over five years, Change in Inventory peaked at $537992.0 in Q1 2026 and troughed at -$421152.0 in Q4 2025.
  • The 4-year median for Change in Inventory is $3405.0 (2023), against an average of $66312.5.
  • The largest YoY upside for Change in Inventory was 31279.84% in 2025 against a maximum downside of 2716.83% in 2025.
  • A 4-year view of Change in Inventory shows it stood at $3405.0 in 2023, then skyrocketed by 372.66% to $16094.0 in 2024, then crashed by 2716.83% to -$421152.0 in 2025, then soared by 227.74% to $537992.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Change in Inventory are $537992.0 (Q1 2026), -$421152.0 (Q4 2025), and $508981.0 (Q3 2025).